entertainment -WSS

entertainment

author：focus 2025-09-29 07:25:25 - browse：398

Biogen, a biotech giant plagued by years of boardroom strife, said late Monday that the longtime and polarizing director Alex Denner would step down from its board, sending a signal to investors that the company’s fractious recent history might be coming to a close.

What Biogen didn’t disclose is that its nominee to replace Denner on the board, Susan Langer, is Denner’s live-in romantic partner and the mother of his child, born in November, according to court records obtained by STAT. Denner is in the middle of a protracted divorce from his wife of nearly 25 years, with whom he has two teenage sons — a bitter legal fight in which his extramarital relationship with Langer is a contentious issue, according to the records.

Biogen spokesperson Jack Cox said the company knew about the relationship between Denner and Langer. He also said that Denner recommended Langer to Biogen’s board — he said he incorrectly stated at first that Denner nominated her — but declined to comment on the company’s vetting process and whether it planned to disclose the relationship to shareholders before they vote on Langer’s candidacy later this month. Biogen also omitted mention of the relationship from Langer’s biography in a Securities and Exchange Commission filing Tuesday morning.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Eight reasons why you should get an updated Covid vaccine

explore

WSS

STAT Readout: Today's biotech news includes Sana and Amylyx

Peter Marks talks Operation Warp Speed for Rare Diseases

AI can’t replace a physician’s gut feeling

Custom gene therapy hints at new path for rare disease treatments

Takeaways from AdvaMed, the largest medical devices conference

How dance can help nurses traumatized by Covid

knowledge

entertainment

focus

Medical leaders decry Supreme Court decision on affirmative action

Nick Jonas talks about managing diabetes along with his career

Medicare details structure of new drug price negotiation program

Wellcome Trust names Røttingen as its new CEO

Medical leaders decry Supreme Court decision on affirmative action

Nick Jonas talks about managing diabetes along with his career

Psychedelics group wrestles with new pharma identity

How dance can help nurses traumatized by Covid

The cancer drug shortage isn’t new — and neither are the solutions

Biden tests positive for Covid

hotspot

STAT Readout: Today's biotech news includes Sana and Amylyx

Readout LOUD podcast: Merger Mondays, Ozempic panic

Humana CEO Bruce Broussard to step down in 2024

Why hospitals are withdrawing from US News rankings

Sanders adds drug shortage policies to pandemic preparedness bill

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

hotspot

leisure time

explore

Wikipedia